Faculty of Science, Department of Biological Sciences, University of Jeddah, Jeddah 21959, Saudi Arabia.
Faculty of Science, Department of Biological Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Nutrients. 2024 Oct 14;16(20):3478. doi: 10.3390/nu16203478.
: Current treatments for inflammatory bowel disease (IBD) are relatively futile and the extended use of drugs may reduce effectiveness. Several probiotic strains have shown promise in relieving/treating IBD symptoms. : The current study investigated the impact of fermented soymilk with a mixture of probiotic starter cultures containing , , , , , and subsp. in rats with dextran sulfate sodium (DSS)-induced colitis compared to control. : Rats were randomly assigned to five groups (5 rats/group; n = 25): G1: negative normal control; G2: positive control (DSS); G3: DSS with sulfasalazine (DSS-Z); G4: DSS with soymilk (DSS-SM), and G5: DSS with fermented soymilk (DSS-FSM). Parameters monitored included the following: the disease activity index (DAI), macroscopic and histological assessments of colitis, and a fecal microbial analysis performed to assess the severity of inflammation and ulceration. : The DSS-FSM rats group exhibited lower DAI scores ( < 0.05) than other treated groups during the induction period. A macroscopical examination revealed no ulceration or swelling in the intestinal mucosa of rats in the DSS-FSM-treated group, resembling the findings in the negative control group. In the positive control (DSS group), the colon tissue showed increased inflammation ( < 0.05), whereas those in the DSS-SM- and DSS-FSM-treated rats groups did not show significant macroscopic scores of colitis. The positive DSS control and DSS-Z groups had crypt erosion and ulceration areas, severe crypt damage, and epithelial surface erosion, which were absent in the negative control and DSS-FSM groups. The counts of spp. and spp. remained stable in both G1 and G5 over 4 weeks. The consumption of fermented soymilk with a mixture of probiotics could minimize the severity of DSS-induced colitis in rats. , it was found that fermented soymilk containing and might be an effective vehicle for reducing the severity of DSS-induced colitis in rats.
目前治疗炎症性肠病(IBD)的方法相对无效,并且药物的长期使用可能会降低疗效。有几种益生菌株在缓解/治疗 IBD 症状方面显示出了希望。本研究调查了与对照相比,在葡聚糖硫酸钠(DSS)诱导的结肠炎大鼠中,含有 、 、 、 、 和 亚种的发酵豆浆与混合益生菌发酵剂混合物的影响。
大鼠被随机分为五组(每组 5 只;n=25):G1:阴性正常对照组;G2:阳性对照组(DSS);G3:DSS+柳氮磺胺吡啶(DSS-Z);G4:DSS+豆浆(DSS-SM),和 G5:DSS+发酵豆浆(DSS-FSM)。监测的参数包括以下内容:疾病活动指数(DAI)、结肠炎的宏观和组织学评估,以及粪便微生物分析,以评估炎症和溃疡的严重程度。
在诱导期,DSS-FSM 大鼠组的 DAI 评分较低(<0.05),低于其他治疗组。宏观检查显示,DSS-FSM 治疗组大鼠的肠黏膜无溃疡或肿胀,类似于阴性对照组的结果。在阳性对照组(DSS 组)中,结肠组织显示出炎症增加(<0.05),而 DSS-SM 和 DSS-FSM 治疗大鼠组则没有明显的结肠炎宏观评分。阳性 DSS 对照组和 DSS-Z 组的隐窝侵蚀和溃疡面积、隐窝严重损伤和上皮表面侵蚀在阴性对照组和 DSS-FSM 组中均不存在。在 4 周内,G1 和 G5 中的 spp. 和 spp. 数量保持稳定。食用含有益生菌混合物的发酵豆浆可以最大程度地减轻大鼠 DSS 诱导的结肠炎的严重程度。综上所述,含有 和 的发酵豆浆可能是减轻大鼠 DSS 诱导的结肠炎严重程度的有效载体。